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Adaptive immunityNatural killer T (NKT) cell activation is responsible for eliminating pathogens. However, the biological
functions of NKT cells against inﬂuenza virus are not fully understood. We therefore investigated the effects
of NKT cells in viral infection using CD1d knockout (KO) mice. When CD1d KO or wild-type (WT) mice were
infected with a sub-lethal dosage of the inﬂuenza virus, the survival rate of CD1d KO mice was signiﬁcantly
lower than for WT mice in association with delayed viral clearance in the lungs. Consistently, IFN-γ
production in bronchoalveolar lavage ﬂuid of CD1d KO mice was largely reduced compared to WT mice
during infection. Moreover, the cytotoxic activities of NK cells and viral antigen-speciﬁc CD8+ T cells were
impaired in CD1d KO mice. It was concluded that activated NKT cell-induced IFN-γ release enhances both
NK-cell activity and antigen-speciﬁc CD8+ T cells to eliminate the inﬂuenza virus, thus leading to an
enhanced survival.a-ku, Tokyo, 142-8555, Japan.
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The immune responses for host defenses are mediated by several
kinds of cells and cytokines both in innate and in adaptive immunity.
Such cells as macrophages, dendritic cells (DCs), natural killer (NK)
cells and NKT cells are involved in the innate immune response. NKT
cells in mice have been deﬁned as the cells that primarily retain an
invariant Vα14-Jα18 rearrangement of the T-cell receptor (TCR) and
reactivity to glycolipids presented by the MHC class I-like molecule
CD1d (Tupin et al., 2007). NKT cells can produce a large number of
cytokines and have surface stimulatory molecules to activate NK cells,
T cells, B cells and DCs (Godfrey and Kronenberg, 2004; Gumperz and
Brenner, 2001). NKT cells therefore appear to be responsible for the
activation of innate immunity and the induction of adaptive
immunity. In addition, because those cells can immediately secrete
a high amount of IFN-γ after activation and stimulate various immune
responses downstream of activated NKT cells, NKT cells therefore play
an important role in quickly protecting the host against infectious
pathogens, including bacteria, virus, parasite and fungus (Diana andLehuen, 2009; Tupin et al., 2007; Van Dommelen and Degli-Esposti,
2004).
Because the CD1d molecule is required for the differentiation of
Vα14+ NKT cells in the thymus, CD1d KO mice lack Vα14+ NKT cells
(Mendiratta et al., 1997; Smiley et al., 1997). These mice have
therefore been used for the functional analyses of NKT cells. A
previous study demonstrated that CD1d KO mice showed markedly
reduced pulmonary eradication of Pseudomonas aeruginosa infections
and the administration of α-galactosylceramide (α-GalCer), which
activates CD1d-restricted NKT cells, rapidly enhanced the pulmonary
clearance of the microorganisms along with a large quantity of IFN-γ
production by NKT cells (Nieuwenhuis et al., 2002). The roles of NKT
cells in antiviral immune responses in mouse have been discussed in
several virus infection models using CD1d KO mice. Impaired viral
clearance was observed in CD1d KO mice infected with the herpes
simplex virus type 1 (Grubor-Bauk et al., 2008, 2003). Moreover,
CD1d KO mice showed increased mortality following a high-dose
murine cytomegalovirus infection (van Dommelen et al., 2003;
Wesley et al., 2008).
A recent mouse study showed that mice administered α-GalCer have
enhanced immune protection against inﬂuenza virus infection in
association with decrease of the virus titer in the lung and an improved
weight loss proﬁle (Ho et al., 2008). However, the immunological
mechanisms in recovery from inﬂuenzavirus infection remainunclariﬁed.
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wereused in thepresent study. Theprotective roles ofNKTcellswere then
investigated in both the innate and adaptive immune responses against
inﬂuenza virus infection.Results
NKT cell-deﬁcient mice exhibit a higher susceptibility to inﬂuenza virus
infection
Initially, CD1d KO or WT mice were intranasally infected with 10,
100 or 1000 pfu/mouse of inﬂuenza virus. When the mice were
infected with 10 pfu/mouse of the virus, no mice died in either the
CD1d KO or WT groups (Fig. 1A). Conversely, the survival rates of the
CD1d KO mice and WT mice infected with 1000 pfu/mouse of the
virus were ultimately less than 17% (survival rate; 1/12 in CD1d KO
vs. 2/12 in WT mice) by the end of the observation period and no
signiﬁcant differences in the survival rate were observed between the
CD1d KO mice and WT mice (Fig. 1C). However, when mice were
infected with 100 pfu/mouse of the virus, which is a sub-lethal viral
dosage, the survival rate of the CD1d KO mice was signiﬁcantly
reduced compared to the WT mice (Fig. 1B). Moreover, as shown in
Fig. 1D, WT mice administered α-GalCer (2 μg/mouse/day×3 days),
which is a speciﬁc activator for NKT cells, during inﬂuenza viral infection
(100 pfu/mouse) markedly protected mice from viral infection in
comparison to control mice, thus suggesting that NKT cells play an
important role in recovering from the pathogenesis of a sub-lethal
dosage of inﬂuenza virus.Fig. 1. The survival rate of CD1d KOmice is lower than that of WTmice during inﬂuenza viru
1000 (C) pfu/mouse of inﬂuenza virus. (D) WTmice were infected with the inﬂuenza virus (
0, 3 and 5. The survival rate was monitored daily until day 20. Twelve mice were evaluatedClearance of inﬂuenza virus and IFN-γ production in impaired lungs in
NKT cell-deﬁcient mice
To measure the viral titer and various cytokine levels in the lungs
during infection, CD1d KO mice and WT mice were sacriﬁced on days
2, 4 and 6 following the infection of 100 pfu/mouse of the inﬂuenza
virus and their BALFs were obtained from each mouse. Fig. 2 shows
that the inﬂuenza virus titer in the BALF of CD1d KO mice was
signiﬁcantly higher (approximately 10-fold) than in WT mice on days
4 and 6. Correspondingly, in CD1d KO mice, such pro-inﬂammatory
cytokines as TNF-α and MCP-1 in BALF were drastically increased
compared to the levels in BALF of WT mice on days 2, 4 and/or 6,
respectively (Fig. 3). On the other hand, the production of IFN-γ,
which retains its anti-viral effects, was clearly impaired in the BALF of
CD1d KO mice. Although the IL-12 p40 production in the CD1d KO
mice was comparable to that in the WT mice, the production of IL-12
p70 was below the detection limits in both WT and KO mice during
the inﬂuenza virus infection (data not shown). These results imply
that IFN-γ plays a critical role in the protection of the host from virus-
mediated pathogenicity.There are no differences in cell migration into the lungs between WT
mice and CD1d KO mice during inﬂuenza virus infection
Analyses of the phenotypes of cells that migrated to the lungs after
inﬂuenza virus infection (100 pfu/mouse) were performed using XT-
2000iV. As shown in Table 1, the numbers of white blood cells (WBC),
neutrophils, monocytes, lymphocytes, eosinophils or basophils in thes infection. CD1d KOmice or WTmice were intranasally infected with 10 (A), 100 (B) or
100 pfu/mouse) and injected with 2 μg/mouse of αGarCer or saline as a control on days
for each group. Similar results were obtained in two independent experiments.
Fig. 2. Delay of the viral clearance in the lungs of CD1d KO mice during inﬂuenza virus
infection. CD1d KO mice or WT mice were intranasally infected with 100 pfu/mouse of
the inﬂuenza virus. On days 2, 4 and 6 after the infection, mice were sacriﬁced and the
BALF supernatant was prepared to measure virus titer. The virus titer was determined
by a plaque assay as described in Materials and methods. Six mice were used in each
group. *pb0.05 compared to the viral titer of WT mice.
Table 1
Changes of cellular composition in the BALF after inﬂuenza virus infection (×105 cell).
Before Day 2 Day 4 Day 6
WBC WT 5±0.5 7±2.6 92±8.2 99±18.7
CD1d K.O. 7±4.2 6±1.6 107±12.1 80±9.4
Neutrophil WT 1±0.6 2±0.9 16±2.6 12±3.2
CD1d K.O. 1±1.2 1±0.8 16±2.0 12±1.3
Monocyte WT 3±0.5 4±1.6 70±4.6 74±8.2
CD1d K.O. 5±3.0 4±1.0 85±11.0 64±8.7
Lymphocyte WT b105 b105 4±0.6 5±1.3
CD1d K.O. b105 b105 5±1.5 4±0.9
Eosiophil WT b105 b105 1±0.3 1±0.2
CD1d K.O. b105 b105 1±0.5 1±0.2
Basophil WT b105 b105 b105 b105
CD1d K.O. b105 b105 b105 b105
The mean and standard deviation from 3 mice/group is shown.
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inﬂuenza virus infection.The enhancement of IFN-γ downstream of activated NKT cells is
responsible for an improved survival rate after inﬂuenza virus infection
Impaired IFN-γ production was observed in CD1d KO mice during
inﬂuenza virus infection (Fig. 3). To conﬁrm whether IFN-γ
production contributes to improved survival rates following infection,
WT mice were treated with a neutralizing anti-IFN-γ Ab or a normal
rabbit IgG1 Ab on days 0 and 5 of infection and the survival rates were
monitored until day 20. As a result, infectedWTmice treated with the
anti-IFN-γ Ab exhibited a lower survival rate in comparison to control
mice (Fig. 4). However, the survival rate of CD1d KO mice given an
anti-IFN-γ Ab was comparable to that of CD1d KO mice treated with
the isotype control (IC) antibody (survival rate on day 20; 1/12 in
anti-IFN-γ Ab treated group vs. 2/12 in IC group). In addition, the
survival of infected mice treated with IC (Fig. 4) was not signiﬁcantly
different from that of infected WT mice (Fig. 1B) (p=0.3954). These
results demonstrated that IFN-γ produced by activated NKT cells
mediates anti-viral immunity downstream of NKT cells.Fig. 3. Differences in cytokine production between CD1d KOmice andWTmice infected with
mouse of the inﬂuenza virus. BALFs were obtained on days 2, 4 and 6 and IFN-γ, IL-12, TNF-
group. *pb0.05, **pb0.01 compared to cytokine productions of WT mice.IFN-γ production enhanced by activated NKT cells enhances the
cytotoxic activity of NK cells
It is well known that IFN-γ enhances the activity of various cells,
thereby mediating cellular immunity. To explore the mechanisms of
IFN-γ production by NKT cells and mediation of the immune
responses against the inﬂuenza virus, NK activity was examined.
The frequency and number of NK cells in the BALF of CD1d KO mice
were comparable to that of WT mice (Fig. 5A and B). The cytotoxicity
of NK cells in BALF on day 6 of infection was examined with a co-
culture system using effector/target (E/T) cell ratios of 30:1, 3:1 and
1:1. The cytotoxicity of NK cells in an E/T ratio of 30:1 was
signiﬁcantly reduced in CD1d KO mice in comparison to WT mice,
although the cytotoxicity of NK cells in an E/T ratio of 3:1 and 1:1
were close to the limit of detection in both groups (Fig. 5C).
IFN-γ production downstream of activated NKT cells also increases CD8+
T cell killing activity
The effects of IFN-γ produced by NKT cells during viral infection on
the number and the function of viral antigen-speciﬁc CD8+ T cells
were next examined. Therewas nodifference in the frequency of CD8+
T cells in the BALF of CD1d KOmice orWTmice (Fig. 6A). However, the
number of CD8+ T cells was signiﬁcantly reduced in CD1d KO mice
comparing to WTmice on day 6 of infection (Fig. 6B). Next, the killing
activity of antigen-speciﬁc CD8+ T cell in the lung was determined
using an in vivo killing assay. CD1d KO mice or WT mice were
transferred with an equal mixture of peptide-pulsed CFSElow cells and
unpulsed CFSEhigh cells on day 6 of infection as described in Materialsthe inﬂuenza virus. CD1d KOmice orWTmice were intranasally infected with 100 pfu/
α and MCP-1 were measured by ELISA in the supernatants. Six mice were used in each
Fig. 4. Neutralization of IFN-γ increases the susceptibility to inﬂuenza virus infection in
WT mice. WT mice intranasally infected with 100 pfu/mouse were intravenously
administered a neutralizing anti-IFN-γ Ab or a normal rabbit IgG1 as an isotype control
on days 0 and 5. The survival rate of the mice was monitored daily until day 20. Twelve
mice were used in each group.
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observed in both CD1d KO mice and in WT mice infected with the
inﬂuenza virus, but was not observed in the non-infected mice. When
the percentage of killing activity was calculated, the activity in CD1d
KO mice infected with the virus was signiﬁcantly reduced in
comparison to the infected WT mice (Fig. 6D).Neutralization of IFN-γ abrogates virus clearance with impaired NK cell
and CD8 T cell cytotoxicity
Neutralization of IFN-γ signiﬁcantly decreased the survival of mice
during inﬂuenza virus infection (Fig. 4). Following this observation,
we investigated whether the neutralization of IFN-γ has an effect on
the virus clearance, cytotoxicity of NK cells or of viral antigen-speciﬁc
CD8+ T cells in the BALF on day 6 of the virus infection. The clearance
of inﬂuenza virus was signiﬁcantly delayed in IFN-γ neutralized mice
compared to control mice (Fig. 7A). In accordance with the delayed
virus clearance, the cytotoxicity of NK cell tended to be lower in mice
treated with the anti-IFN-γ Ab than mice treated with IC (Fig. 7B). Of
note, the viral antigen-speciﬁc cytotoxicity of CD8+ T cells in IFN-γ
neutralized mice was signiﬁcantly abrogated compared to that in
control mice, and the cytotoxicity of CD8 T cells was abolished almost
completely by IFN-γ neutralization.Fig. 5. Migration to the lung and cytotoxic activity of NK cells after inﬂuenza virus infecti
inﬂuenza virus. (A) Cells in the BALFs were analyzed by ﬂow cytometry and CD49b-positive a
in the BALFs was calculated. (C) The cells in the BALFs were considered to be effector cells
titrated effector cells and YAC-1 cells were mixed at various effector/target (E/T) ratios as
methods. *pb0.05 compared to the viral titer of WT mice.Asialo-GM1 positive and CD8 positive cells are responsible for IFN-γ
production during inﬂuenza virus infection
Because IFN-γ production downstream of NKT cell activation plays
a crucial role in protecting animals from inﬂuenza virus infection,
candidates cells responsible for the production of IFN-γ activated by
NKT cells were investigated in vivo using antibody depletion on day 6
of the infection. As shown in Fig. 8, IFN-γ production in WT mice was
signiﬁcantly higher than that in CD1d KO mice (as was also indicated
in Fig. 3). When either the anti-CD8 Ab or anti-asialo GM1 Ab used to
deplete the cells expressing the molecules were administrated to
infected WT mice, the IFN-γ in the BALF decreased to a level
comparable to infected CD1d KO mice. However, the administration
of an anti-CD4 Ab did not lead to this effect. These results suggest that
the major source of IFN-γ on day 6 after infection was the asialo-GM1
positive and CD8 positive cells. It is therefore likely that activated NKT
cells stimulate CD8+/asialo-GM1+ cells, thus resulting in an en-
hanced IFN-γ production in the cells.
Discussion
Studies using such knockoutmice as CD1d or Jα18 and studies using
αGalCer havebeenmainly used to investigate the roles ofNKT cells in an
infectious mouse model (Duthie et al., 2005; Exley et al., 2001;
Gonzalez-Aseguinolaza et al., 2000; Johnson et al., 2002; Kakimi et al.,
2000).While accumulating reports suggest that NKT cells play a pivotal
role in eliminating infective microorganisms including bacteria, virus,
parasite and fungus, the effect ofNKT cells on immune responses against
inﬂuenza virus infection has yet to be elucidated (De Santo et al., 2008;
Ho et al., 2008; Tupin et al., 2007; Van Dommelen and Degli-Esposti,
2004). In the present study, it has been demonstrated that IFN-γ
induced by activated NKT cells inmice infected with the inﬂuenza virus
enhances the cytolytic activities both of NK cells and viral antigen-
speciﬁc CD8+ T cells to eliminate the virus. Various kinds of immune
cells produce IFN-γ. Although NKT cells are the primary members for
innate immunity, IFN-γ involving in activated NKT cells is essential for
innate immunity through NK cell activation and in adaptive immunity
through Ag-speciﬁc CTL activation as presented in this study.
It has been reported that one immune modulatory function of IFN-γ
produced by activated NKT cells is to rapidly enhance both the
cytotoxicity and IFN-γ production of NK cells for host innate immunity
(Carnaud et al., 1999). Our results provide evidence that CD1d KO mice
with impaired IFN-γ production or neutralization of IFN-γ in infected
WT mice exhibit incomplete cytotoxicity of NK cells after inﬂuenza viruson. CD1d KO mice or WT mice were intranasally infected with 100 pfu/mouse of the
nd CD3-negative lymphocytes were identiﬁed to be NK cells. (B) The number of NK cells
and were prepared from CD1d KO mice or WT mice on day 6 following infection. The
indicated. The cytotoxicity percentages were calculated as described in Materials and
Fig. 6.Migration of CD8+ T cells to the lung and the antigen-speciﬁc cytotoxicity of CD8+ T cells following inﬂuenza virus infection. CD1d KOmice orWTmice were intranasally infected
with100pfu/mouse of the inﬂuenzavirus. (A) The cells in theBALFswere stainedwith a PE-anti-CD8αAbandaFITC-anti-CD3εAbandwere analyzedbyﬂowcytometry. CD8-positive and
CD3-positive lymphocytes were identiﬁed to be CD8+ T cells. (B) The number of CD8+ T cells in the BALFs was calculated. (C) Ten million cells, equally composed of NP147-155 pulsed
CFSElow cells andunpulsedCFSEhigh cells,were injected i.v. into non-infectedmice, infectedCD1dKOmice or infectedWTmice onday 6 following inﬂuenza virus infection. Fourhours later,
micewere sacriﬁced and the lungs removed prior to the FCM analyses. The representative data of six individualmice fromnon-infectedmice, infectedWTmice or infected CD1d KOmice
are shown. (D) Percentage of in vivo killing activity for infected CD1d KO mice or infected WT mice were calculated as indicated in Materials and methods.
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infected cells due to detection of the lack of MHC class I expression, the
depletion of NK cells increases the susceptibility to inﬂuenza virus
infection, therefore leading to higher morbidity and mortality rates
(Stein-Streilein and Guffee, 1986). Moreover, it has recently been shown
that the natural cytotoxicity receptors NKp46 and NKp44 on human NK
cells recognize inﬂuenza virus hemagglutinins (HA) on virally infected
target cells (Arnon et al., 2001; Mandelboim et al., 2001). Subsequently,
the natural cytotoxicity receptor 1 (NCR1) on NK cells in mice was
identiﬁed to be a mouse homolog of human NKp46 and lacking NCR1
resulting in increased morbidity and mortality in vivo with insufﬁcient
eradication of the inﬂuenza virus (Gazit et al., 2006). These reportssuggest that NK cell activation is responsible for the primary host
defense against inﬂuenza virus infection in innate immunity.
The ability of virus-speciﬁc cytotoxic CD8+ T cells to thoroughly
prevent the inﬂuenza virus from escaping from the innate immune
response has been demonstrated in CD8+ T cell-deﬁcient mice (Bender
et al., 1992). Although the number of viral antigen-speciﬁc CD8+ T cells
in the lungs during inﬂuenza virus infection was not determined in
present study, some reports have clearly demonstrated that viral
antigen-speciﬁc CD8+ T cells inﬁltrate the lungs from around day 3
following infection and that their migration is enhanced by α-GalCer
treatment (Ho et al., 2008). Moreover, both invariant NKT cells and
CD1d molecule-dependent CD8+ T cell migration to the lungs have
Fig. 7. Effects of neutralization of IFN-γ on virus clearance, cytotoxicity of NK cells, and antigen-speciﬁc CD8+ T cells following inﬂuenza virus infection. CD1d KO mice or WT mice
were intranasally infected with 100 pfu/mouse of the inﬂuenza virus and 25 μg/mouse of anti-IFN-γ Ab or an equivalent amount of IC were administrated i.v. on days 0 and 5. (A)
The virus titer in the BALF was measured by plaque assay on day 6 after the virus infection. Six mice were used in each group. (B) NK cell cytotoxicity in the BALF was determined on
day 6 following infection as described in Materials andmethods. The effector cells and YAC-1 cells were mixed at a 30:1 (E/T) ratio. (C) The cytotoxicity of virus-speciﬁc CD8+ T cells
in the lungs was determined on day 6 following infection, as described in Materials and methods. Four mice were used in each group.
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(NP) peptide was used to measure the antigen-speciﬁc killing activity
of CD8+ T cells in the present study, as demonstrated by Wysocka and
Bennink (1988), the authors clearly showed that the cytotoxic CD8+ T
cell responses against inﬂuenza virus infection in BALB/c (H-2Kd) mice
are dominated by clones reactive to the viral NP, in which approximately
75% of cytotoxic CD8+ T cells are NP-reactive clones and the other viral
proteins share the remains. Our ﬁndings indicate that defective IFN-γ
production in CD1d KO mice or neutralization of IFN-γ in infected WT
mice lead to impaired activation of cytotoxic CD8+ T cells in vivo and
may be associated with a higher mortality and delayed clearance of the
virus escaping from the innate immunity. Stober et al. (2003) have
reported that NKT cells contribute to DC-dependent priming of MHC-
class I restricted CD8+ T cells. However, the direct effect of DCs on
priming Ag-speciﬁc CTL could not be shown in this study, but we
hypothesize that the present results are consistent with those ﬁndings.
The major IFN-γ producing cells in mice infected with inﬂuenza
virus were also identiﬁed by this study. We showed that both CD8
positive and asialo-GM1 positive cells are the major IFN-γ producing
cells on day 6 after infection, although the phenotypic features andFig. 8. The inﬂuence of IFN-γ production on inﬂuenza virus infection following
antibody-mediated cell depletion. CD1d KOmice orWTmice were intranasally infected
with 100 pfu/mouse of the inﬂuenza virus and 25 μg/mouse of anti-CD4 Ab or anti-CD4
Ab or 50 μ of anti-asialo GM1 serum, respectively, were i.v. injected on days−3, 0 and 3.
Mice were sacriﬁced on day 6 after the virus infection and IFN-γ in the BALF was
measured by ELISA assay. Five mice were used for each group.kinetics of the cells have not yet been precisely identiﬁed. It has been
reported that CD8+/asialo-GM1+ cells, which comprise only 3% of the
naïve BALB/c CD8+ T cells in splenocytes, are major producers of IFN-
γ among the CD8+ cell population upon stimulation with anti-CD3
(Kosaka et al., 2007). It is plausible that CD8+/asialo-GM1+ cells
might be a subpopulation of NKT cells. However, CD8+ NKT cells have
only been reported in human lymphocytes (Kulkarni et al.,), so CD8+
NKT cells can be ruled out as the major IFN-γ producing cells in this
study.
There are two activation pathways from DCs to NKT cells; direct
activation and indirect activation (Tupin et al., 2007). In some types of
bacterial infections, NKT cells can directly recognize several bacterial
glycolipid antigens. For example, phosphatidylinositol tetramanno-
side (PIM4) and monogalactosyl diacylglycerol lipids are recognized
in Mycobacteria spp. and Borrelia burgdoferi infection, respectively
(Kinjo et al., 2006, 2005; Mattner et al., 2005). On the other hand, it
has not yet been reported that NKT cells recognize lipid antigens
derived from viral particles (Cerundolo et al., 2009). It appears that
indirect activation of NKT cells is the primary pathway in viral
infections. In indirect NKT cell activation following viral infection,
there have been reported two pathways, the endogenous antigen-
and cytokine-mediated pathways (Tupin et al., 2007). In the
endogenous antigen-mediated pathway, NKT cells can be promptly
activated by inﬂammatory cytokines from antigen-presenting cells
that recognize microorganisms in combination with CD1d-mediated
presentation of endogenous ligands derived from viral infection. In
the cytokine-mediated pathway, viral TLR ligands are recognized by
the TLRs of DCs, and cytokines such as IL-12 and IL-18 are released
from the DCs and are sufﬁcient for IFN-γ production of NKT cells (Brigl
et al., 2003; Nagarajan and Kronenberg, 2007; Van Dommelen and
Degli-Esposti, 2004). However, because antigen presentations via
CD1d are not required in the cytokine pathway, this pathway is likely
not involved in the inﬂuenza virus infection model of the present
study.
Recently, De Santo et al. (2008) demonstrated that invariant NKT
cells regulate the migration and function of myeloid-derived
suppressor cells (MDSCs) during inﬂuenza virus infection. They also
demonstrated that one of the mechanisms responsible for controlling
MDSCs is the suppressive function by invariant NKT cells through
CD1d and CD40 molecules on MDSCs. Therefore, lung MDSCs induced
by inﬂuenza virus infection suppress the expansion and function of
viral antigen-speciﬁc CD8+ T cell immune responses in the absence of
invariant NKT cells resulting in a high virus titer and increased
mortality. Impaired virus clearance and decreased function of viral
antigen-speciﬁc CD8+ T cells was found to be associated with CD1d
331H. Ishikawa et al. / Virology 407 (2010) 325–332KO mice during inﬂuenza virus infection in the present study,
suggesting that MDSCs may be involved in the impaired CD8+ T cell
functions in infected CD1d KO mice.
In conclusion, the current study provides evidence that NKT cells are
important in inducing fully functional innate and adaptive immune
responses to eliminate the inﬂuenza virus from an infected host. Our data
also suggest that this protective mechanism may be dependent on
sufﬁcient IFN-γ downstream of the activated NKT cells activated by
cytokines derived from DCs that recognize microorganisms. Future
researchwill examine theefﬁcient control of innate andadaptive immune
responses against the HINI swine ﬂu and H5N1 avian inﬂuenza virus by
utilizing αGalCer administration.
Materials and methods
Mice
BALB/c femaleWTmice (6 weeks of age) were purchased from the
Oriental Yeast Co., LTD. (Tokyo, Japan). CD1d KO mice, bred on a
BALB/c background, were bred in our experimental animal facility. All
mice were housed under speciﬁc pathogen-free conditions according
to the animal protocol guidelines of the Committee on Animal Care of
Tokyo Medical University (protocol No. S-47).
Inﬂuenza virus infection and treatment protocols
Inﬂuenza virus A/Puerto Rico/8/34 (PR8, H1N1) strain was kindly
provided by Dr. Kawaoka at the University of Tokyo. Mice were
anesthetized and intranasally infected with 20 μl of saline containing
the virus. Day 0 was deﬁned as the day of viral infection throughout
the experiments and the survival was monitored daily until 20 days
after the infection. In some experiments, mice were administered by
intraperitoneally (i.p.) administered 2 μg/mouse of αGalCer (Kirin
Holding Company, LTD. Tokyo, Japan) on days 0, 3 and 5. For the
neutralization of IFN-γ, 25 μg/mouse of anti-IFN-γ Ab (clone:
XMG1.2) (BD Pharmingen, CA, USA) or an equivalent amount of
normal rabbit IgG1 as a control (clone: R3-34) (BD Pharmingen) were
intravenously (i.v.) injected on days 0 and 5. To deplete speciﬁc cell
types, themicewere injected intravenously with 25 μg/mouse of anti-
CD4 Ab (clone: H129.19), anti-CD8 Ab (clone: 53-6.7) or 50 μl/mouse
of anti-asialo GM1 Ab on days -3, 0 and 3, respectively.
Plaque assay
CD1d KO mice and WT mice were in intranasally infected with 100
pfu/mouse of inﬂuenza virus and the virus titers in bronchoalveolar
lavage ﬂuid (BALF) were determined by a plaque titration. Conﬂuent of
Madin Darby canine kidney (MDCK) cells in 12well plateswerewashed
three times with serum-free DMEM and subsequently with DMEM
supplemented with 0.5% BSA, 100 μg ml−1 DEAE dextran, 1 μg ml−1
TPCK-treated trypsin, 100 U ml−1 penicillin and 100 μg ml−1 strepto-
mycin (Sigma, MO, USA) were added in each well followed by
incubation with serially diluted BALF supernatants at 33 °C for 1 h.
After gently washing, the cells were overlaid with the medium
containing 0.9% agar and were maintained in 5% CO2 at 33 °C for
3 days. The agarmediawere then removed and the cellswereﬁxedwith
5% formalin solution and stained with a 0.1% crystal violet solution.
Cytokine assay in BALF
The concentration of cytokines in the BALF supernatants were
measured using a mouse IFN-γ ELISA development kits, mouse IL-12
p40 ELISA development kits, mouse IL-12 p70 ELISA development kits,
mouse TNF-α ELISA development kits and a mouse CCL2/JE/MCP-1
immunoassay kit (R&D systems, MN, USA) according to the manufac-
turer's instructions as described previously (Ishikawa et al., 2008).Analysis of cell migration into the lungs following virus infection
To evaluate the number of cells migrating the lung after inﬂuenza
virus infection, the cells in the BALF obtained from uninfected or
infected mice were washed with PBS, and their number and type of
cells were analyzed by XT-2000iV, which is an automatic blood cell
analysis apparatus (Sysmex corporation, Hyogo, Japan).
Flow cytometric analysis
The ﬂow cytometric (FCM) analyses for cells in BALF were performed
ona FACSCaliburﬂowcytometerwith theCellquest Pro softwareprogram
as previously described (Ishikawa et al., 2007). The cells were stained in
PBS with 1% BSA and then ﬁxed with 1% paraformaldehyde. The
antibodies used in the present study were anti-CD16/CD32 Ab (clone:
2.4G2) as an Fc receptor-blocker, FITC-conjugated anti-CD3ε Ab (clone:
145-2C11), FITC-conjugated anti-CD49b Ab (clone: DX5), PE-conjugated
anti-CD3εAb (clone: 145-2C11) and PE-conjugated anti-CD8αAb (clone:
53-6.7) (BD Pharmingen).
Cytotoxic activity assay for NK cells
The cytotoxicity of NK cell in BALFs were examined by a co-culture
system with YAC-1 cells as the target cell (Noda et al., 2001) and the
levels of lactate dehydrogenase (LDH) in the culture supernatants,
which is an enzyme released upon cell lysis, were measured using the
CytoTox 96 non-radioactive cytotoxicity assay kit (Promega,WI, USA).
To prepare the effector cells, cells in BALFs were obtained from CD1d
KO mice or WT mice on day 6 of infection. Serially titrated effector
cells were co-cultured with 1×105 cell/ml of target cells (YAC-1) in
DMEM supplemented with 10% FCS, 100 U ml-1 penicillin and
100 μg ml−1 streptomycin in a 96-well-round bottom microplate at
37 °C for 4 h. The level of LDH in the culture supernatants was then
measured and the NK cell cytotoxicity was calculated according to the
manufacturer's protocol.
In vivo killing assay
An in vivo killing assay for antigen-speciﬁc CD8+ T cells was
performed as described (Barber et al., 2003), and single splenocytes
from naïve mice were stained with a PKH26 red ﬂuorescent cell linker
kit for general cell membrane labeling (Sigma). The cells were
separated into two equal populations prior to labeling with 50 nM
CFSE (Sigma) (deﬁned as CFSElow) or 500 nM CFSE (deﬁned as
CFSEhigh). The CFSElow cells were pulsed with 10 μM of nucleoprotein
(NP) 147-155 of the inﬂuenza virus PR8 strain, which is the TYQRTRALV
peptides sequence-restricted MHC class I (H-2Kd), for 30 min, while
CFSEhigh cells were not pulsed. After washing, the two populations
were mixed in equal proportions and 1×107 cells were injected i.v.
into the non-infected control mice or mice infected with inﬂuenza
virus on day 6. At 4 h after the injection, lungs were removed from the
mice and single cells were analyzed by an FCM to measure the levels
of cytotoxicity. The percent of killing activity was calculated by the
following formula: Percent of killing activity=100–{[(% CFSElow in
infected mice/% CFSEhigh in infected mice)/(% CFSElow in uninfected
mice/% CFSEhigh in uninfected mice)]×100}.
Statistical analysis
The statistical analyses were performed using the Stat View Ver. 5
software program (SAS Institute Inc., NC, USA). The statistical signiﬁ-
cance of the ﬁndings was calculated using the Mantel-Cox log rank test
for survival experiments. The unpaired t-test was used for the in vitro
assay. p-Values of less than 0.05 were considered to be statistically
signiﬁcant. All values are represented as the mean ± standard deviation.
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